Effect of acute pharmacological blockade of renin-angiotensin system on intrarenal hemodynamics in patients with sle and scleroderma systematica

Terapevticheskii Arkhiv

Volumn 73, Issue 6, 2001, Pages 20-25

  Bugrova, O V ^a   Kutyrina, I M ^a   Bagirova, V V ^a   Morozova, E V ^a   Gromova, M M ^a  

^a NONE

Author keywords

ACE inhibitors; Captopril; Chronic sclerodermic nephropathy; Intrarenal hemodynamics; Lupus nephritis

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; DOPPLER ECHOGRAPHY; DRUG EFFECT; ECHOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC SCLEROSIS; VASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; SCLERODERMA, SYSTEMIC; SOFTWARE; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 0035236555     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bjoerck S. B., Mulec H., Johnsen S. A. et al. Renal protective effect of enalapril in diabetic nephrophathy. Br. Med. J. 1992; 304: 339-343.
2. Mathiesen E., Hommel E., Giese J. et al. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent patients with microalbuminuria. Ibid. 1991; 303: 1-87.
3. Ganservoort R. T., Heeg G. E., Dikkeschei F. D. et al. Symptomatic antiproteinuric treatment deasese serum lipoprotein (a) concentration in patients with glomerular proteinuria Nephrol Dial. Transplant. 1994; 9: 244-250.
4. Bakris G. L., Weir M. R., DeQuattro V. et al. Effects of an ACE ingibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int. 1998; 54: 1283-1289.
5. Morrisey J. J., Shigeto Ishidoya, McCracken R. et al. The effect of ACE inhibitor on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Ibid. 1996; 49 (suppl. 54): S83-S87.
6. Shapira Y., Mor F., Friedler A. et al. Antiproteinuric effect of captopril in a patient with lupus nephrithis and intractable nephrotic syndrom. Ann. Rheum. Dis. 1990; 49: 725-727.
7. Platt J. F. Duplex Doppler evaluation of native kidney dysfunction: obstructive and nonobstructive disease. Am. J. Roentgenol. 1992; 158: 1035-1042.
8. Ishimura E., Nishizawa Y., Kawagishi T. et al. Intrarenal hemodynamic abnomalitis in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int. 1997; 51: 1920-1927.
9. Sauvain J. L., Bourscheid D., Girardot M. N. et al. Echo Doppler renal index de resistance de Pourcelot et nephrophathie diabetique: Interet et signification. Rev. Im. Med. 1994; 6: 151-158.
10. Dishocho C. C. The kidney in progressive systemic sclerosis (scleroderma). In: The Kidney in systematic deasese. New York; 1976. 57-74.
11. Le Roy E. C., Black C., Fleischmayer R. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 1988; 15: 202-205.
12. Kondo H., Yanagida K., Ushida K., Kashiwasaki S. Renal involvement in progressive systematic sclerosis. Ann. Intern. Med. 1982; 22 (4): 293-300.